Search
![Alexander Callo](/sites/default/files/styles/card_410x307_/public/images/2022-10/Callo_Alexander_LinkedIn.jpg?h=915cd633&itok=kOUVHrIi)
Alex Callo represents clients in high stakes intellectual property litigation, with a specific focus on complex pharmaceutical patent litigation under the Hatch-Waxman Act. His experience includes drafting motions and pleadings, research, and analyzing discovery. Alex has a background in both...
![William Baton's Headshot](/sites/default/files/styles/card_410x307_/public/images/2022-08/Baton_William_LinkedIn.jpg?h=40c24adf&itok=K65MBbuy)
Bill Baton represents pharmaceutical companies in complex, often high-profile, patent litigation. Bill concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical companies. He currently serves as New Jersey litigation counsel in more...
![Leah D. Leyendecker](/sites/default/files/styles/card_410x307_/public/images/2022-08/Leyendecker_Leah_LinkedIn.jpg?h=40c24adf&itok=Q85PqgxA)
Leah Leyendecker focuses her practice on commercial transactions driven by intellectual property, intangible assets and technology. Her experience includes reviewing, drafting and negotiating complex technology-related license and master services agreements, SaaS agreements, technology development...
Intellectual property is often a company’s strongest asset, one that can be protected and leveraged to gain a competitive advantage. It is critical for companies of all sizes to effectively protect and enforce their intellectual property. Saul Ewing’s team of attorneys and patent agents with diverse...